Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: Anti dandruff shampoo Selenium sulfide (2.5%): Approximately 5ml ofshampoo will be applied and massaged on the wet scalp. It will be left on for 2-3 minutes after which it will be rinse
Sponsors
Abbott Healthcare Private Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary men and/or women with moderate Dandruff (score > 10 as per scale mentioned). 2. Age: 18 to 70 years 3. Having signed a Consent Form after being informed orally and in writing of all information concerning the study procedures and study objectives. 4. Ready to comply with the study specifications 5. Willing to refrain from use of all other topical medications that would affect the results of the trial, including medicated shampoos/oils or antibiotics, during the treatment periods.
Exclusion criteria
Exclusion criteria: 1. Pregnancy by UPT or Lactating women. 2.History or presence of compromising dermatosis elsewhere on the skin 3.History or presence of Parkinsons disease, HIV, infections or disorders of the central nervous system 4. Have used an antidandruff agent in the past 14 days 5. Presence of any skin condition that would interfere with the diagnosis or assessment of dandruff,e.g., psoriasis, acne, atopic dermatitis 6. Clinically significant systemic disease (e.g., immunological deficiencies, AIDS, current malignancies, uncontrolled diabetes mellitus) 7. Use within 1 month prior to baseline of any treatment that would affect the results of the trial, including a) systemic antifungals, b) systemic steroids, c) systemic antibiotics d) systemic anti-inflammatory agents or e) cytostatic or immunomodulating drugs (e.g. cyclosporine, tacrolimus, pimecrolimus) or f) systemic retinoids 8. Use within 2 weeks prior to baseline of any treatment that would affect the results of the trial, including a) topical steroids, b) topical retinoids, c) topical anti-inflammatory agents, d) topical antibiotics or e) topical treatment of adherent dandruff (e.g., coal tar preparation, antidandruff shampoo or oils or gels or creams or conditioners, f) antihistamines. 9. Participant in an exclusion period or already participating in another similar cosmetic or therapeutic trial as identified during screening on visit 1 (V1). 10. Actinically damaged skin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Clinical Evaluation for reduction in dandruff. Timepoint: Day 0, Week 1, Week 2, Week 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Self evaluation for reduction in dandruff 2. Instrument evaluation of Sebum reduction.Timepoint: Day 0, Week 1, Week 2, Week 4 | — |
Countries
India
Contacts
Public ContactR B Mohile
C.L.A.I.M.S. Pvt. Ltd.
Outcome results
None listed